|
Volumn 301, Issue 1, 2002, Pages 77-86
|
Novel glutathione-dependent thiopurine prodrugs: Evidence for enhanced cytotoxicity in tumor cells and for decreased bone marrow toxicity in mice
a,b b a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
6 (2 ACETYLVINYLTHIO)GUANINE;
6 (2 ACETYLVINYLTHIO)PURINE;
6 MERCAPTOPURINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
BUTANE;
GLUTATHIONE;
MALEIC ACID DIETHYL ESTER;
MERCAPTOPURINE;
PRODRUG;
TIOGUANINE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
BONE MARROW TOXICITY;
CELL LEVEL;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG EFFECT;
DRUG METABOLISM;
DRUG STRUCTURE;
DRUG UPTAKE;
HUMAN;
IC 50;
LEUKOCYTE COUNT;
LIVER TOXICITY;
MALE;
MOUSE;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
AREA UNDER CURVE;
BONE MARROW DISEASES;
CARCINOMA, RENAL CELL;
CELL SURVIVAL;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
GLUTATHIONE;
GUANINE;
HEPATITIS, TOXIC;
HUMANS;
KIDNEY DISEASES;
MICE;
OXIDATION-REDUCTION;
PRODRUGS;
PURINES;
SPECTROPHOTOMETRY, ULTRAVIOLET;
TUMOR CELLS, CULTURED;
|
EID: 0036129205
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: 10.1124/jpet.301.1.77 Document Type: Article |
Times cited : (31)
|
References (40)
|